HHS-NIH11 · uncategorized
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. In addition to supporting...
Deadline
2027-01-07
Funding range
Not listed
Days remaining
90 days
Cost-sharing required
No
Who can apply
- independent_school_districts
- small_businesses
- for_profit_organizations_other_than_small_businesses
- special_district_governments
- nonprofits_non_higher_education_without_501c3
- nonprofits_non_higher_education_with_501c3
- city_or_township_governments
- federally_recognized_native_american_tribal_governments
- other_native_american_tribal_organizations
- public_and_state_institutions_of_higher_education
- public_and_indian_housing_authorities
- state_governments
- private_institutions_of_higher_education
- county_governments
- other
General screening signals
These automated scores use broad defaults. They do not know your organization and are not an eligibility determination or recommendation to apply.
- · Applicant and source gates score 10/100.
- · Mission evidence scores 32/100 for education, youth, community.
- · Geographic fit scores 80/100; restrictions still require notice review.
- · Funding and organizational-capacity fit scores 45/100.
- · Deadline urgency scores 45/100 with 89 days remaining.
- · Application burden appears low.
Plan your application
Keep this notice beside your working checklist
Download the complete official notice and its amendments, then organize your own review in NOFO Workspace. Keep exact source excerpts beside your tasks and notes.
The workspace uses the documents you import. This directory summary does not replace the full notice, its linked guides or agency instructions.